Related Experiment Video
Updated: Jul 11, 2026
Corneal and Limbal Alkali Injury Induction Using a Punch-Trephine Technique in a Mouse Model
Published on: August 4, 2023
[Persistent corneal defects treated with botulinum toxin-induced ptosis]
E N Vleming1, C Pérez-Rico, M A Montes
1Servicio de Oftalmología del Hospital Universitario Príncipe de Asturias, Alcalá de Henares, Madrid, Spain. e_vleming@yahoo.es
Objectives:
To evaluate the use of botulinum toxin (BTX) induced ptosis in the treatment of corneal pathology.
Methods:
We employed two BTX injections into the superior lid of 10 eyes (9 patients). We evaluated the degree of ptosis, its duration and the effect on the corneal lesion.
Results:
Complete ptosis resulted in seven eyes and the corneal pathology resolved in all of them. There were no relevant complications.
Conclusions:
BTX treatment is a simple and safe technique for treating refractory corneal pathology. It has significant advantages over surgical tarsorrhaphy and is especially useful where the pathology does not require surgery.
